Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 19, 2023 - Issue
Submit an article Journal homepage
124
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits

Alexandra Arias-Mendoza1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5942-4102
ORCID Icon,
Jorge A Ortega-Hernández1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoORCID Iconhttps://orcid.org/0000-0002-6019-2644
ORCID Icon,
Diego Araiza-Garaygordobil1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoORCID Iconhttps://orcid.org/0000-0003-3185-0051
ORCID Icon,
Héctor González-Pacheco1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoORCID Iconhttps://orcid.org/0000-0002-4370-9963
ORCID Icon,
Mireya Martínez-García2 Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoORCID Iconhttps://orcid.org/0000-0002-2876-8500
ORCID Icon,
Enrique Hernández-Lemus3 Computational Genomics, Instituto Nacional de Medicina Genómica, Mexico City, MexicoORCID Iconhttps://orcid.org/0000-0002-1872-1397
ORCID Icon,
Rodrigo Gopar-Nieto1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoORCID Iconhttps://orcid.org/0000-0002-4865-4869
ORCID Icon,
Tomás Tadeo Sandoval-Aguilar1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, MexicoORCID Iconhttps://orcid.org/0000-0002-7032-0371
ORCID Icon,
Daniel Sierra-Lara Martinez1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
,
Salvador Mendoza-García1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
,
Alfredo Altamirano-Castillo1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
,
José Luis Briseño-de-la-Cruz1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
,
Midori Alondra Ortega-Hernández4 Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico
,
Luis Alejandro Soliz-Uriona1 Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
&
Jorge Gaspar-Hernández5 Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
 show all
Pages 903-911 | Received 23 Aug 2023, Accepted 30 Oct 2023, Published online: 09 Nov 2023

References

  • Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationThe Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/EURHEARTJ/EHX393
  • Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368(15):1379–1387. doi:10.1056/NEJMoa1301092
  • Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004;364(9439):1045–1053. doi:10.1016/S0140-6736(04)17059-1
  • Baeza-Herrera LA, Araiza-Garaygordobil D, Gopar-Nieto R, et al. Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST segment elevation at the National Institute of Cardiology (PHASE-MX). Arch Cardiol Mex. 2020;90(2):158–162. doi:10.24875/ACM.19000185
  • PIB per cápita. Cuéntame de México. Available from: https://cuentame.inegi.org.mx/economia/pibpc.aspx?tema=e. Accessed May 11, 2023.
  • Zubaid M, Khraishah H, Alahmad B, et al. Efficacy and safety of pharmacoinvasive strategy compared to primary percutaneous coronary intervention in the management of ST-segment elevation myocardial infarction: a Prospective Country-Wide Registry. Ann Glob Health. 2020;86(1). doi:10.5334/AOGH.2632
  • Mohan VN, Alexander T, Muraleedharan VR, et al. Economic and societal impact of a systems-of-care approach for STEMI management in low and middle-income countries: insights from the TN STEMI program. Ann Glob Health. 2019;85(1):122–123. doi:10.5334/AOGH.2508/METRICS/
  • Hira RS, Bhatt DL, Fonarow GC, et al. Temporal trends in care and outcomes of patients receiving fibrinolytic therapy compared to primary percutaneous coronary intervention: insights from the Get With the Guidelines Coronary Artery Disease (GWTG-CAD) registry. J Am Heart Assoc. 2016;5(10). doi:10.1161/JAHA.116.004113
  • Rashid MK, Guron N, Bernick J, et al. Safety and efficacy of a pharmacoinvasive strategy in ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2016;9(19):2014–2020. doi:10.1016/j.jcin.2016.07.004
  • Bainey KR, Armstrong PW, Zheng Y, et al. Pharmacoinvasive strategy versus primary percutaneous coronary intervention in ST-elevation myocardial infarction in clinical practice: insights from the Vital Heart Response Registry. Circ Cardiovasc Interv. 2019;12(10). doi:10.1161/CIRCINTERVENTIONS.119.008059

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.